Personas / Equipo Humano

Judith Usall I Rodié

Buscador de publicaciones

Publicaciones

  • del Cacho N, Butjosa A, Vila R, Cuadras-Palleja D, Kaplan M, Rubio E, Pardo M, Muñoz D, Cuevas-Esteban J, GERARDO SAENZ DE NAVARRETE RIBERA, PROFEP group and Usall J.

    Prolactin levels in drug-naive first episode nonaffective psychosis patients compared with healthy controls. Sex differences

    PSYCHIATRY RESEARCH . 276: 218-222. Nº de citas: 10

    [doi:10.1016/j.psychres.2019.03.027]

  • Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.

    Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.

    EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Nº de citas: 7

    [doi:10.1111/eip.12498]

  • Ballesteros A, Sánchez-Torres AM, López-Ilundain JM, Cabrera B, Lobo A, González-Pinto AM, Díaz-Caneja C, Corripio I, Vieta E, de la Serna E, Bobes J, Usall J, Contreras F, Lorente-Omeñaca R, Mezquida G, Bernardo M, Cuesta MJ and PEPs Group.

    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    PSYCHOLOGICAL MEDICINE . 48(13): 2247-2256. Nº de citas: 35

    [doi:10.1017/S0033291717003774]

  • Paipa N, Stephan-Otto C, Cuevas-Esteban J, Araceli Núñez Navarro, Usall J and Brebion G.

    Second-to-fourth digit length ratio is associated with negative and affective symptoms in schizophrenia patients.

    SCHIZOPHRENIA RESEARCH . 199: 297-303. Nº de citas: 10

    [doi:10.1016/j.schres.2018.02.037]

  • Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.

    Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.

    BMJ Open . 8(7): . Nº de citas: 6

    [doi:10.1136/bmjopen-2017-021346]

  • Soria V, González-Rodríguez A, Huerta-Ramos ME, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group and Labad J.

    Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.

    PSYCHONEUROENDOCRINOLOGY . 93: 8-19. Nº de citas: 49

    [doi:10.1016/j.psyneuen.2018.04.012]

  • Sánchez Autet M, Garriga M, Zamora FJ, González I, Usall J, Tolosa L, Benítez C, Puertas R and Arranz B.

    Screening of alcohol use disorders in psychiatric outpatients: influence of gender, age, and psychiatric diagnosis.

    Adicciones . 30(4): 251-263. Nº de citas: 4

    [doi:10.20882/adicciones.885]

  • Farreny A, Usall J, Cuevas-Esteban J, Ochoa S and Brebion G.

    Amendment of traditional assessment measures for the negative symptoms of schizophrenia.

    EUROPEAN PSYCHIATRY . 49: 50-55. Nº de citas: 3

    [doi:10.1016/j.eurpsy.2017.11.003]

  • Brebion G, Stephan-Otto C, Ochoa S, María de Lourdes Nieto García, Contel M and Usall J.

    Verbal fluency in male and female schizophrenia patients: Different patterns of association with processing speed, working memory span, and clinical symptoms.

    Neuropsychology . 32(1): 65-76. Nº de citas: 16

    [doi:10.1037/neu0000394]

  • Nuñez C, Theofanopoulou C, Carl Senior, Cambra-Martí MR, Usall J, Stephan-Otto C and Brebion G.

    A large-scale study on the effects of sex on gray matter asymmetry.

    BRAIN STRUCTURE & FUNCTION . 223(1): 183-193. Nº de citas: 12

    [doi:10.1007/s00429-017-1481-4]